• Information for centres
    • Protocol and appendices
    • Eligibility Criteria
    • CRFs and completion guidelines
    • Patient related documents
    • Essential documents
    • Pharmacy Documents
    • Sub-Studies
    • Training Slides
    • FAQs
  • Publications
  • Monthly Accrual
  • Newsletters


Home Page > Centres > Information for centres > CRFs and completion guidelines

CRFs and completion guidelines

.

 

>Randomisation form

>Baseline form 

>Cardiovascular assessment form 

>Pathology form 

>Bone density risk factor questionnaire

 

>Bisphosphonate treatment form, before 18 weeks

>Bisphosphonate treament form, after 18 weeks

>Docetaxel treatment form

 

>Follow up form

>Follow up form (post-progression)

[Please note: We no longer have a post-2 years, pre-progression follow-up form]

 

>Progression & additional treatment form

>Additional treatment update form [New form]

>Radiotherapy form

>Late radiotherapy toxicity form

>Palliative radiotherapy form

>End of treatment form

>Death form

>EQ-5D Quality of Life form

>SAE form

>Co-enrolment form [New form]

>Bone mineral density sub-study assessment form [only for patients on the Bone Mineral Density Substudy]

>Withdrawal Form

 

CRF completion guidelines

>CRF completion guidelines Version 2.0 - Coming soon!

 

Common toxicity criteria for adverse events (CTCAE)

>CTCAE V3.0



Accessibility | Webmaster | Sitemap | Contact Us | Home
© 2011 STAMPEDE, Medical Research Council Clinical Trials Unit